NCT02614404View on ClinicalTrials.gov

Effect of Imatinib on Suppression of Malaria Parasites in Patients With Uncomplicated Plasmodium Falciparum Malaria

PHASE1CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

November 30, 2015

Primary Completion Date

December 2, 2016

Study Completion Date

February 2, 2017

Conditions
Plasmodium Falciparum Malaria
Interventions
DRUG

Imatinib combination therapy

Imatinib plus dihydroartemisinin plus piperaquine

DRUG

Dihydroartemisinin-piperaquine

Standard of care

Trial Locations (1)

520000

A Tuc, Hương Hóa

All Listed Sponsors
collaborator

Purdue University

OTHER

collaborator

University of Turin, Italy

OTHER

collaborator

Università degli Studi di Sassari

OTHER

collaborator

Hue University

OTHER

lead

HuLow

INDUSTRY

NCT02614404 - Effect of Imatinib on Suppression of Malaria Parasites in Patients With Uncomplicated Plasmodium Falciparum Malaria | Biotech Hunter | Biotech Hunter